The role of systemic chemotherapy in the management of muscle-invasive bladder cancer
- 1 December 2002
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (12), 738-747
- https://doi.org/10.1016/s1470-2045(02)00930-0
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Stat Bite: U.S. Urinary Bladder Cancer Death RatesJNCI Journal of the National Cancer Institute, 1999
- PELVIC LYMPH NODE DISSECTION CAN BE CURATIVE IN PATIENTS WITH NODE POSITIVE BLADDER CANCERJournal of Urology, 1999
- Adjuvant chemotherapy for high‐risk urothelial transitional cell carcinoma: the Princess Margaret Hospital experienceBritish Journal of Urology, 1998
- Concurrent Cisplatin and Radiotherapy for Patients with Muscle Invasive Bladder Cancer Who are not Candidates for Radical CystectomyJournal of Urology, 1996
- Uncertainty and outcome of invasive bladder tumorsUrologic Oncology: Seminars and Original Investigations, 1996
- Identification of p53 Gene Mutations in Bladder Cancers and Urine SamplesScience, 1991
- THE MANAGEMENT OF INVASIVE BLADDER CANCER: A REVIEW OF SELECTED AUSTRALASIAN STUDIES IN RADIOTHERAPY, CHEMOTHERAPY AND CYSTECTOMYAnz Journal of Surgery, 1991
- Adjuvant Chemotherapy of Bladder Cancer: A Preliminary ReportJournal of Urology, 1988
- Prognostic indices for bladder cancer: An analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapyRadiotherapy and Oncology, 1986